WO1989002730A1 - Separate storage container - Google Patents

Separate storage container Download PDF

Info

Publication number
WO1989002730A1
WO1989002730A1 PCT/JP1988/000980 JP8800980W WO8902730A1 WO 1989002730 A1 WO1989002730 A1 WO 1989002730A1 JP 8800980 W JP8800980 W JP 8800980W WO 8902730 A1 WO8902730 A1 WO 8902730A1
Authority
WO
WIPO (PCT)
Prior art keywords
piercing
chamber
storage
container
separation
Prior art date
Application number
PCT/JP1988/000980
Other languages
French (fr)
Japanese (ja)
Inventor
Norisuke Kira
Kazuhiko Sudo
Original Assignee
Terumo Kabushiki Kaisha
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Terumo Kabushiki Kaisha filed Critical Terumo Kabushiki Kaisha
Priority to DE1988908369 priority Critical patent/DE395758T1/en
Priority to EP88908369A priority patent/EP0395758B1/en
Priority to DE3850781T priority patent/DE3850781T2/en
Publication of WO1989002730A1 publication Critical patent/WO1989002730A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61JCONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/14Details; Accessories therefor
    • A61J1/20Arrangements for transferring or mixing fluids, e.g. from vial to syringe
    • A61J1/2093Containers having several compartments for products to be mixed
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B65CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65DCONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
    • B65D81/00Containers, packaging elements, or packages, for contents presenting particular transport or storage problems, or adapted to be used for non-packaging purposes after removal of contents
    • B65D81/32Containers, packaging elements, or packages, for contents presenting particular transport or storage problems, or adapted to be used for non-packaging purposes after removal of contents for packaging two or more different materials which must be maintained separate prior to use in admixture
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61JCONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/05Containers specially adapted for medical or pharmaceutical purposes for collecting, storing or administering blood, plasma or medical fluids ; Infusion or perfusion containers
    • A61J1/10Bag-type containers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61JCONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/14Details; Accessories therefor
    • A61J1/20Arrangements for transferring or mixing fluids, e.g. from vial to syringe
    • A61J1/2003Accessories used in combination with means for transfer or mixing of fluids, e.g. for activating fluid flow, separating fluids, filtering fluid or venting
    • A61J1/2006Piercing means
    • A61J1/201Piercing means having one piercing end
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61JCONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/14Details; Accessories therefor
    • A61J1/20Arrangements for transferring or mixing fluids, e.g. from vial to syringe
    • A61J1/2003Accessories used in combination with means for transfer or mixing of fluids, e.g. for activating fluid flow, separating fluids, filtering fluid or venting
    • A61J1/202Separating means
    • A61J1/2027Separating means having frangible parts

Definitions

  • the present invention relates to a container for separating and storing two or more substances, and more particularly, to a method for dissolving a solute in a storage chamber in a solute storage member storing a solute such as a powdery or liquid drug.
  • the present invention relates to a separation container in which a solvent such as a liquid can be sent, and a solute such as a powdery or liquid drug can be mixed and dissolved aseptically.
  • solute drugs are dissolved in a solvent dissolution medium just before being injected intravenously into a patient. There are many reasons for this, but the typical one is that once a drug is dissolved in a lysis solution, its effectiveness can only be maintained for a short period of time. For this reason, when administering powdered drugs such as antibiotics conventionally contained in a solute container forming a solute container village to a patient, the following method is used in conventional methods. Methods were generally adopted.
  • an appropriate amount of a physiological saline solution, a 5% glucose injection solution or the like is sucked with a syringe, and the powdered drug is contained in the solute container. Then, the needle of the syringe was pierced, the lysing solution was injected, and after the powdered drug was dissolved, the patient was again sucked with the syringe and injected into the patient.
  • a second example is containing a powdered drug, as disclosed in, for example, Japanese Patent Publication No. 59-500600
  • the solute container and the bag enclosing the dissolving solution are aseptically connected by an adapter forming a communicating means holding the piercing needle and the breakage portion, and the dissolving solution is stored with the powdered drug.
  • the drug solution was injected into the solute container, and the powdered drug was dissolved. This solution was returned to the bag again, and the patient was infused intravenously.
  • a sleeve formed of a flexible material that is arranged so as to surround the piercing needle and that expands and contracts in response to the movement of the needle is shown.
  • a solute vessel containing a powdered drug and a lysing solution as disclosed, for example, in U.S. Pat. No. 4,844,920.
  • an assembling bag which are aseptically connected to each other by a needle or an adabuta having a broken part, and the lysing solution is put into the solute container. Dissolve the powdered drug, then use the empty bag as an air vent to completely dissolve the antibiotics, etc., return the solution back to the bag, and inject the solution intravenously into the patient.
  • the above-mentioned conventional example still has various problems to be solved. That is, in the case of the first example, the solution, the syringe, and the container containing the powdered drug are separately prepared, and these operations are performed in a facility such as a clean bench capable of performing aseptic work. Operation complexity, There is also a risk of bacterial contamination.
  • a sterile facility such as a clean bench is not required, the piercing portion provided in the solute container containing the powdered drug and the piercing needle on the adapter are not required.
  • the solute container and the adapter are connected incorrectly, or the operator is required when necessary, because there is no means to positively maintain the separated state during normal non-use.
  • problems such as the complicated connection operation and the complicated structure of the adapter.
  • the piercing portion provided on the solute container and the piercing needle on the adapter are actively separated when not in use. There was a danger of accidentally piercing the connection between the solute container and the adabuta, because there was no means to maintain the condition. Further, in the case S of this example, the liquid in which the powdered drug is dissolved enters the empty bag during the use operation, and the liquid is returned to the bag containing the dissolved liquid again.
  • problems such as the difficulty of
  • the present invention solves the above-mentioned problems of the conventional separation and storage container, and has a simple structure.
  • the piercing section of one of the two receiving members and the piercing element that can pierce the piercing element when necessary are actively kept apart from each other, and the piercing section is operated when used.
  • the user easily and reliably performs the above-described piercing operation, and aseptically connects the chamber of one of the storage members and the chamber of the other storage member that contains the other substance to perform the required mixing (dissolution).
  • An object of the present invention is to provide a medicine container which can perform an action and is easy to operate.
  • a first housing member having an outlet and a first chamber in which a first substance is accommodated, and a second accommodation member which accommodates a second substance and has a piercing portion.
  • a stimulating element that allows the piercing portion of the second housing member to pierce with a predetermined piercing resistance when necessary, and a piercing element that extends into the first chamber, and
  • a closing portion that closes communication between the first chamber and the piercing element and is separable when required, and has a closing portion that allows the communication to be performed when the first chamber is separated; It is assumed that there is a communication means' for aseptically communicating between the first chamber and the second chamber, and a further configuration.
  • the present invention provides a method for controlling the communication between a second housing member and a first chamber, wherein the second housing member surrounds the stimulating element and is always pierced by the second housing member.
  • the piercing element and the piercing element are held in the chick state, and when an external force of a predetermined value or more along the axial direction of the piercing element is applied, the piercing element is plastically deformed along the axial direction. Then, the piercing part is allowed to pierce the piercing element and the holding means for maintaining the piercing state is provided, and the piercing element is stimulated by the piercing element. It has been made Later, by separating the closing part of the communication means, aseptic communication between the first chamber and the second chamber is performed through the communication means. It proposes a separate storage container.
  • the holding means can positively hold the piercing element of the second housing member and the piercing element of the communication means in a separated state, It is possible to prevent accidentally performing a piercing operation.
  • the external force that is, the force applied by the operator
  • the holding means is plastically deformed. As a result, the piercing operation is performed, and the piercing state is securely held by the plastically deformed holding means.
  • the separation and storage container of the present invention has a small number of components, has a simple structure, and has a sterile condition because the communicating portion forming the communicating means is sealed. If the external force in the axial direction does not apply to the guide cover serving as the holding means, the guide force bar will not be plastically deformed, so the piercing needle that forms the piercing element of the communicating part There is almost no chance of accidentally piercing the piercing section. However, since there are no empty knocks, the melting operation is easy.
  • the predetermined value of the external force for plastically deforming the holding means is set in the dog based on the piercing resistance of the piercing element to the piercing portion.
  • 3 K gf or more preferably in the range of 3 K gf to 5 K gf, particularly preferred. It is assumed to be 3.5 K gf.
  • the holding means is constituted by a guide cover integrally formed in a bellows shape by blow molding of a thermoplastic resin, for example.
  • the outwardly protruding ridges of the guide cover in the form of a jar are thinner and easier than the valleys that are recessed inward. Since it can be formed into a shape, suitable characteristics as a guide cover can be obtained.
  • FIGS. 1 to 4 show an embodiment of the present invention.
  • FIG. 1 is a perspective view of a medicine container covered with a packaging material
  • FIG. FIG. 3 is an enlarged perspective view of the medicine container in the state
  • FIG. 3 is an enlarged vertical sectional view of the medicine container shown in FIG. a)
  • (b), (c) and (d) are explanatory views showing the usage state of the medicine container, respectively
  • FIG. 5 is a perspective view of the medicine container showing another embodiment of the present invention. .
  • FIG. 1 is a perspective view of a drug storage container forming a separation storage container of the present invention covered with a packaging material
  • FIG. 2 is a perspective view of the drug storage container. It is.
  • 1 and 1 indicate a drug container
  • the drug container 1 is made of a flexible synthetic resin sheet
  • the storage chamber 2 and the storage chamber 3 are independent of each other. And are integrally formed.
  • the medicine container 1 is entirely covered with a rectangular packaging material 4, and is a solvent described below, which is sealed in the storage chamber 2 by the packaging material 4. The stability of the dissolution solution S is guaranteed.
  • Dissolution liquid S for example, physiological
  • a discharge port 5 is provided at the lower part of the storage chamber 2, and the discharge port 5 is further covered with an aluminum tube 6, so that the solution S does not go outside. ing .
  • Boundary part 1 b is shaped
  • a communication section 9 is provided as communication means having a bottle needle or a piercing needle 8 forming a communication element.
  • the communicating portion has a cylindrical shape in which an end in the storage chamber 2 is closed, and a notch is formed in an inner peripheral surface so that the closing portion 7 is easily broken by an external force.
  • the bottle needle 8 is provided with a return blade 8a, which makes it difficult for the piercing portion 11 to be described later to be pulled out.
  • the middle part of the cylindrical communication part 9 is held at the boundary part 1b.
  • Glass or resin solute storage member 3 ⁇ 4 formed vial or solute container 10 is stored in storage room 3, and powder 1 is contained in chamber 1 Ob in this vial 10.
  • the antibiotic A which is a solute, enters.
  • a rubber stopper 11 is inserted into the mouth 10a of this nodal 10 to form a piercing portion through which the above-mentioned bottle needle 8 can be pierced, and is fixed by a mouthpiece 1 la ( ( Figure 3).
  • a guide cover 12 in the form of a bellows is provided between the mouth 10a of the vial 10 and the bottom 3a of the storage chamber 3 formed by the boundary lb in FIG. I have.
  • the guides 1 and 2 constitute the holding means.
  • the guide cover 12 applies an external force greater than a predetermined value by an operator's hand from the outside in the axial direction of the bottle needle 8, that is, the bottle needle 8 of the communication portion 9 is connected to the vial 10.
  • a material that plastically deforms when it is put in the direction that penetrates the rubber plug 11 fitted into the mouth 10a for example, a metal material such as aluminum or a thermoplastic material such as polypropylene. It is composed of resin.
  • the bottle needle 8 is held at a separated position as shown in FIG. 3, and the rubber stopper 11 can be pierced.
  • the lysing solution S does not accidentally enter the vial 10.
  • the guide cover 12 guides the bottle needle 8 to prevent the bottle needle 8 from being accidentally pierced except for the rubber stopper 11. Further, if the guide cover 12 is deformed and contracted, since it is plastically deformed, the deformed state is maintained, so that the piercing state of the bottle needle 8 is reliably maintained. As shown in FIG. 3, one end 12a of the guide cover 12 surrounds the mouth 10a of the dial and the rubber stopper 11 as well as the Fixed to dial 10. The other end 12b of the guide canopy 12 extends in the axial direction while surrounding the bottle needle 8 and is fixed to the bottom 3a.
  • the peaks of the guide cover 12 that protrude outward in the radial direction are formed. Since the portion 12c is thinner than the valley portion 12d which is recessed inward in the radial direction, better stretchability than the guide cover 12 can be obtained.
  • the prescribed value of the external force that causes the guide cover 12 to plastically deform is equivalent to the resistance when the needle 8 pierces the rubber stopper 11 of the nominal 10, that is, the piercing resistance. Or higher.
  • the piercing resistance is about 3 Kgf. Therefore, the predetermined value of the guide cover 2 is set to 3 Kgf as the minimum value in this case. Good.
  • the upper limit of the predetermined value corresponds to the external force that can be applied by the operator, but the predetermined value is set in the range of 3 Kgf to 5 Kgf in consideration of the easiness of operation, and particularly preferably 3 Kgf. It is 5 Kgf.
  • the guide cover 1 2. is formed of a metal material, it is preferable to use a method of press molding.
  • the packaging material 4 shown in FIG. 1 that covers the medicine container 1 is removed.
  • the bottle needle 8 of the communication part 9 is guided by a predetermined external force into the rubber stopper 11 fitted to the boiler 10 Oa of the neutral 10 housed in the storage room 3.
  • the cover 12 ⁇ is plastically deformed in the axial direction and contracted by being plastically pierced (see FIG. 4 (a)).
  • the closed portion 7 of the communication portion 9 is not broken or separated and the vial 10
  • the reservoir and the storage chamber 2 are communicated via the communication part 9 (see FIG. 4 (b)).
  • the dissolving solution S sealed in the storage chamber 2 is injected into the vial 10 via the communication section 9 with the storage chamber 2 up and the vial 10 down. Dissolve the antibiotic A in the vial 10 in powder. The solution obtained by dissolving the powdered antibiotic A is returned to the storage chamber 2 with the vial 10 upward and the storage chamber 2 downward. The above procedure is repeated to completely dissolve the antibiotic A in the powder in the vial 10 (see Fig. 4 (c)).
  • the hole 1a of the medicine container 1 is passed through the hanger 14 of the infusion stand 13 and the medicine container 1 is hung on the hanger 14 (see FIG. 4 (d)). That is, the medicine container 1 is hung on the hanger 14 with the storage chamber 2 containing the liquid in which the powdered antibiotic A is dissolved down.
  • the infusion set 15 includes a bottle needle 1 _ 6 piercing the discharge ⁇ 5, a drip tube 1, a clamp 18, and an intravenous needle 19 pierced into a blood vessel or the like of the patient M. And a tube 20 connecting them.
  • the IV needle of the infusion set 15 19 is pierced into the blood vessel or the like of the patient M, the bottle needle 16 is removed from the aluminum cap 6 placed on the discharge port 5, and pierced into the discharge port 5 to clean the bottle. Adjust the method 18 and inject the liquid in which the antibiotic A in the powder in the storage chamber 2 of the medicine container 1 is dissolved into the patient M by intravenous drip.
  • the packaging material 4 (Fig. 1) was prepared after the antibiotic A was dissolved in the dissolution solution S by the piercing operation described above, and before being set in the infusion stand 13. You can remove it.
  • FIG. 5 shows another embodiment of the present invention, and since it has substantially the same configuration as the embodiment shown in FIG. 2, the same parts are denoted by the same symbols and their description is omitted. I do.
  • the medicine storage container 1 has a flexible synthetic resin sheet in which the independent storage chamber 2 and the storage chamber 3 are integrally formed.
  • the storage room 2 and the storage room 30 are integrated.
  • the storage chamber 30 has a cylindrical shape with a janitor-shaped portion 3'0a formed on the outer peripheral surface.
  • a hanging device 21 is attached to the end face of the storage room 3 ⁇ .
  • the other configuration and operation are the same as those in the embodiment shown in FIG.
  • 30a ensures that the guide cover 12 is plastically deformed in the axial direction, and the piercing state of the penetration element 8 is confirmed. It has effects such as the following.
  • the configuration of the storage chamber 2 and the solute container 10 disclosed in the above embodiment is reversed, and In addition to the configuration in which a piercing portion is provided and a piercing element is provided on the solute container side, various modifications are possible without departing from the gist of the present invention. However, it is not limited to this.
  • the separation container according to the present invention is preferably used as an infusion bag for connecting a transfusion set to inject a drug intravenously into a patient. It can be widely used in fields where powdery or liquid solutes need to be aseptically dissolved in solvents.
  • the present invention is applicable not only to the field of medicine for treating drugs and the like, but in the embodiment, the drug container is disclosed as an example of the separation container of the present invention. Therefore, the scope of the present invention is not limited to those related to “drugs” in a narrow sense.

Abstract

A communication section (9) has a piercing needle (8) capable of piercing through a piercing section (11) of a solute container (10) storing therein a solute such as a drug, and a closing section (7) which is separable inside a storage chamber (2) storing therein a solvent. The communication section (9) is disposed between the solute container and the storage chamber, and a bellows-like guide cover (12) covers the piercing needle. Accordingly, the piercing needle is positively kept separated from the piercing section when not in use and the guide cover undergoes plastic deformation under an external force exceeding a predetermined value when in use, thereby permitting the piercing operation to be initiated and then maintained. Due to the subsequent separation of the closing section, the solute and the solvent are mixed through the communication section and sterile dissolution can be ensured.

Description

'明 細 書  'Specification
分 離 収 納 容 器  Separation container
技術分野  Technical field
本発明 は、 2 以上の物質を分離 し て収納す る容器に関 し 、 特に粉末状の若 し く は液状の薬剤等の溶質を収容 し て い る溶質収容部材内に、 貯溜室内の溶解液等の溶媒を 送 り 、 粉末状若 し く は液状の薬剤等の溶質を混合 し て無 菌的に溶解す る こ と が出来る分離収納容器に関する 。 背景技術 '  The present invention relates to a container for separating and storing two or more substances, and more particularly, to a method for dissolving a solute in a storage chamber in a solute storage member storing a solute such as a powdery or liquid drug. The present invention relates to a separation container in which a solvent such as a liquid can be sent, and a solute such as a powdery or liquid drug can be mixed and dissolved aseptically. Background technology ''
溶質をなす多 く の薬剤は患者に静脈注射さ れる 直前に 溶媒を な す溶解液 に溶解さ れ る 。 こ の理由 は種 々 あ る が、. その代表的な も のは、 薬剤が溶解液に溶解さ れる と その有効性を短期間 し か維持出来ない こ と であ る 。 こ の ため、 '従来、 溶質収容部村をなす溶質容器内に収容さ れ てい る抗生物質.等の粉末薬剤を患者に投与する場合、 従 - 来 · 'に お い て 以下 の 'よ う な 方法 が一般 的 に 採 ら れ て い た。  Many solute drugs are dissolved in a solvent dissolution medium just before being injected intravenously into a patient. There are many reasons for this, but the typical one is that once a drug is dissolved in a lysis solution, its effectiveness can only be maintained for a short period of time. For this reason, when administering powdered drugs such as antibiotics conventionally contained in a solute container forming a solute container village to a patient, the following method is used in conventional methods. Methods were generally adopted.
ま ず 、 第 1 の例 にお い て は 、 注射器 に て生理的食塩 水、 5 %ブ ド ウ糖注射液等の溶解液を適量吸引 し 、 粉末 薬剤を収容 し て.い る溶質容器内に注射器の針を剌通 し 、 溶解液を注入 し 、 粉末薬剤を溶解後、 注射器にて再び吸 引 し て患者に注射 し ていた。  First, in the first example, an appropriate amount of a physiological saline solution, a 5% glucose injection solution or the like is sucked with a syringe, and the powdered drug is contained in the solute container. Then, the needle of the syringe was pierced, the lysing solution was injected, and after the powdered drug was dissolved, the patient was again sucked with the syringe and injected into the patient.
第 2 の例 と し て は、 例えば、 特許公表昭 59 - 5 0 0 6 0 0号 公報に 開示さ れて い る よ う に 、 粉末薬剤を収容 し てい る 溶質容器 と 溶解液を封入 しているバ ッ グ と を、 刺通針 と 破断部 と を保持し た連通手段をなすアダプタにて無菌的 に連結 し て、 溶解液を粉末薬剤が収納さ れている溶質容 器に注入 し 、 粉末薬剤を溶解し、 こ の溶液を再びバ ッ グ に戻 し 、 患者に点滴静注し ていた。 A second example is containing a powdered drug, as disclosed in, for example, Japanese Patent Publication No. 59-500600 The solute container and the bag enclosing the dissolving solution are aseptically connected by an adapter forming a communicating means holding the piercing needle and the breakage portion, and the dissolving solution is stored with the powdered drug. The drug solution was injected into the solute container, and the powdered drug was dissolved. This solution was returned to the bag again, and the patient was infused intravenously.
又、 .こ こ においては、 刺通針を取囲むよ う に配置さ れ る と と も に針の移動に応 じ て伸縮する柔軟材料で形成さ れたス リ 一ブが示さ れている 。  In addition, here, a sleeve formed of a flexible material that is arranged so as to surround the piercing needle and that expands and contracts in response to the movement of the needle is shown. .
更に第 3 の例 と し ては、 例えば、 米国特許第 4 . 4 8 4 , 9 2 0号明細書に開示さ れている よ う に、 粉末薬剤を収容 し て い る溶質 器と溶解液を封入 しているバ ッ グと空バ ツ グ と で構成され、 これら を相互に針や破断部を有する ァ ダブタ にて無.菌的に連結 して、 溶解液を前記溶質容器に 入れて粉末薬剤を溶解し 、 こ の時、 空バ ッ グを空気抜き と し て使用 し て抗生物質等を完全に溶解し 、 こ の溶液を 再びバ.ッ グに戻し 、 患 に点滴静注レていた。  Further, as a third example, a solute vessel containing a powdered drug and a lysing solution, as disclosed, for example, in U.S. Pat. No. 4,844,920. And an assembling bag, which are aseptically connected to each other by a needle or an adabuta having a broken part, and the lysing solution is put into the solute container. Dissolve the powdered drug, then use the empty bag as an air vent to completely dissolve the antibiotics, etc., return the solution back to the bag, and inject the solution intravenously into the patient. Was.
又、 こ こ において も、 第 2 'の例 と 同様に刺通針を取囲 む柔軟で伸縮自在なス リ ーブない しブーツが示されてい る 。  Also here, as in the second example, a flexible and stretchable sleeve or boot surrounding the piercing needle is shown.
しか し なが ら 、 上記従来例では未だ解決すべき種々 の 問題があ っ た。 すなわち、 上記第 1 の例の場合溶解液、 ' 注射器、 粉末薬剤を収容 し た容器を別々 に準備し 、 ク リ ー ンベンチ等の無菌作業を行える設備内で、 こ れらの操 作を行なわなければな らず、 操作の煩雑さ 、 外部か らの 細菌汚染の虞 も あ る 。 上記第 2 の例の場合は、 ク リ ー ン ベ ン チ等の無菌設備は必要ない も のの 、 粉末薬剤を取 容 し た溶質容器に設けた刺通部 と アダプタ上の刺通針と を、 通常の不使用時に離間状態に積極的に保持す る手段 を備え て いないため に、 溶質容器 と ア ダプタ と が誤っ て 接続 さ れた り 、 そ の必要時に お い て は 、 操作者 に と つ て 、 接続操作が煩雑であ っ た り 、 し か も 、 ア ダプタ の構 造が複雑な どの問題があ る 。 However, the above-mentioned conventional example still has various problems to be solved. That is, in the case of the first example, the solution, the syringe, and the container containing the powdered drug are separately prepared, and these operations are performed in a facility such as a clean bench capable of performing aseptic work. Operation complexity, There is also a risk of bacterial contamination. In the case of the second example above, although a sterile facility such as a clean bench is not required, the piercing portion provided in the solute container containing the powdered drug and the piercing needle on the adapter are not required. The solute container and the adapter are connected incorrectly, or the operator is required when necessary, because there is no means to positively maintain the separated state during normal non-use. However, there are problems such as the complicated connection operation and the complicated structure of the adapter.
又、 上記第 3 の例の場合は、 こ れも上記第 2 の例 と 同 様 に溶質容器に設け た刺通部 と ア ダプ タ 上の刺通針 と を、 不使用時に積極的に離間状態に保持す る手段を備え ないために、 誤っ て不用意に刺通さ れて溶質容器 と ァダ ブタ の接続がなさ れる危険があ っ た。 更に 、 こ の例の場 Sに は 、 使用操作時に空バ ッ グ内に粉末薬剤を溶解 し た 液が入っ て し ま い、 その液を再び溶解液の入っ たバ ッ グ 内に戻す操作が容易でない等の問題があ っ た。  Also, in the case of the third example, similarly to the second example, the piercing portion provided on the solute container and the piercing needle on the adapter are actively separated when not in use. There was a danger of accidentally piercing the connection between the solute container and the adabuta, because there was no means to maintain the condition. Further, in the case S of this example, the liquid in which the powdered drug is dissolved enters the empty bag during the use operation, and the liquid is returned to the bag containing the dissolved liquid again. However, there were problems such as the difficulty of
従っ て、 本発明は上述の よ う な従来の分離収納容器の 有す る諸問題を解消 し 、 構造が簡単 な も の で あ り な.が ら 、 通常の不使用時には一方の物質を収容 し た一方の収 容部材の刺通部 と 、 こ れを必要時に刺通可能な刺通エ レ メ ン 卜 と を積極的に離間状態に保持す る と と も に使甩時 には操作者が容易且つ確実に上記の刺通操作を行なっ て その一方の収容部材の室 と他方の物質を収容 し た他方の 収容部材の室 を無菌的 に接続 し て所要の混合 ( 溶解) 作用 を行なわせる こ と が出来、 しか も操作が容易な薬剤 収納容器を提供す る こ と を目 的 と する 。 Therefore, the present invention solves the above-mentioned problems of the conventional separation and storage container, and has a simple structure. The piercing section of one of the two receiving members and the piercing element that can pierce the piercing element when necessary are actively kept apart from each other, and the piercing section is operated when used. The user easily and reliably performs the above-described piercing operation, and aseptically connects the chamber of one of the storage members and the chamber of the other storage member that contains the other substance to perform the required mixing (dissolution). An object of the present invention is to provide a medicine container which can perform an action and is easy to operate.
発明の開示 Disclosure of the invention
上記の 目 的 を達成する ために、 本発明 においては、 上 記第 2 及び第 3 の従来例に開示の共通の構成を出発点 と す る 。 ·  In order to achieve the above object, in the present invention, a common configuration disclosed in the above-described second and third conventional examples is taken as a starting point. ·
すなわち 、 排出口 を有し且つ内部に第 1 の物質が収容 さ れた第 1 の室を有する第 1 の収容部材と 、 第 2 の物質 を収容す る と共に刺通部を有する第 2 の収容部材と 、 前記第 2 の収容部材の刺通部を必要時所定の刺通抵抗 を も っ て刺通可能な剌通エレ-メ ン 卜 と前記第 1 の室内に 延出 し て常時は当該第 1 の室と刺通エ レメ ン 卜 と の連通 を閉鎖する と共に必要時に分離可能であ り 、 分離 した と き に前記の連通を行なわせる閉鎖部と を有し 、 必要時に 第 1 の室 と第 2 の室 と の無菌的連通を行なわせる連通手 段'と 、 よ り なる構成を前提と する。  That is, a first housing member having an outlet and a first chamber in which a first substance is accommodated, and a second accommodation member which accommodates a second substance and has a piercing portion. A stimulating element that allows the piercing portion of the second housing member to pierce with a predetermined piercing resistance when necessary, and a piercing element that extends into the first chamber, and A closing portion that closes communication between the first chamber and the piercing element and is separable when required, and has a closing portion that allows the communication to be performed when the first chamber is separated; It is assumed that there is a communication means' for aseptically communicating between the first chamber and the second chamber, and a further configuration.
上記構成について本発明は、' 第 2 の収容部材と第 1 の 室と の間に配置さ れる と と も に剌.通エ レメ ン 卜 を囲み且 つ常時は第 2 の収容部材の刺通部と刺通エ レメ ン 卜 と を 雛間状態に保持する と と も に刺通エレメ ン ト の軸方向に 沿 う 所定値以上の外力が加わ っ た時に当該軸方向に沿つ て塑性変形 し て刺通部に対する刺通エ レメ ン 卜 の剌通を 許容す る と共に当該刺通状態を保持する保持手段が設け られ、 剌通エ レ メ ン ト に よ り 剌通部への剌通がなさ れた 後、 連通手段の閉鎖部が分離さ れる こ と に よ り 、 連通手 段を介 し て第 1 の室 と 第 2 の室 と の間の無菌的連通が行 なわれる構成を特徴 と す る分離収納容器を提案す る も の で あ る 。 With respect to the above-described configuration, the present invention provides a method for controlling the communication between a second housing member and a first chamber, wherein the second housing member surrounds the stimulating element and is always pierced by the second housing member. The piercing element and the piercing element are held in the chick state, and when an external force of a predetermined value or more along the axial direction of the piercing element is applied, the piercing element is plastically deformed along the axial direction. Then, the piercing part is allowed to pierce the piercing element and the holding means for maintaining the piercing state is provided, and the piercing element is stimulated by the piercing element. It has been made Later, by separating the closing part of the communication means, aseptic communication between the first chamber and the second chamber is performed through the communication means. It proposes a separate storage container.
上記の構成に よ り 、 保持手段が第 2 の収容部材の剌通 部に対 して連通手段の刺通エ レメ ン 卜 と を離間状態に積 極的 に保持す る こ と がで き 、 不用意に誤っ て刺通動作が な さ れる の を防止で き る 。 そ し て 、 必要な使用時に は、 外力、 つ ま り 操作者の手操作で加え られる力を所定値以 上に若干.強 く 加え る こ と に よ り 保持手段が塑性変形 し 、 こ れに よ つ て 、 刺通動作がなさ れ、 又、 刺通状態が塑性 変形 し た保持手段に よ り 確実に保持さ れる 。  According to the above configuration, the holding means can positively hold the piercing element of the second housing member and the piercing element of the communication means in a separated state, It is possible to prevent accidentally performing a piercing operation. In addition, when necessary, when the external force, that is, the force applied by the operator, is slightly applied to a value higher than a predetermined value, the holding means is plastically deformed. As a result, the piercing operation is performed, and the piercing state is securely held by the plastically deformed holding means.
従っ て、 本発明の分離収納容器は構成要素が少ないか ら 、 構造が簡単であ り 、 連通手段をなす連通部は密封さ れてい る か ら無菌状態になつ てお り 、 更に、. 所定以上の 軸方向の外力が保持手段を なすガイ ド カ バ一にかから な い と ガイ ド 力 バ―が塑性変形 し ないので、 連通部の刺通 エ レ メ ン 卜 をなす刺通針は刺通部を不用意に誤っ て刺通 す る こ と がほ と ん どない。 し か も空のノ ッ グな どがない か ら溶解操作 も容易な どの効果があ る 。  Therefore, the separation and storage container of the present invention has a small number of components, has a simple structure, and has a sterile condition because the communicating portion forming the communicating means is sealed. If the external force in the axial direction does not apply to the guide cover serving as the holding means, the guide force bar will not be plastically deformed, so the piercing needle that forms the piercing element of the communicating part There is almost no chance of accidentally piercing the piercing section. However, since there are no empty knocks, the melting operation is easy.
好ま し い本発明の具体的構成にお いては、 保持手段を 塑性変形さ せる外力の所定値は、 刺通部に対す る刺通ェ レ メ ン 卜 の刺通抵抗 よ り 犬 に 設定 さ れ 、 例 え ば 3 K g f 以上、 好 ま し く は 3 K gf 〜 5 K gf の範囲内で、 特に好ま し く は、 3 . 5 K gf と さ れる。 In a preferred specific configuration of the present invention, the predetermined value of the external force for plastically deforming the holding means is set in the dog based on the piercing resistance of the piercing element to the piercing portion. For example, 3 K gf or more, preferably in the range of 3 K gf to 5 K gf, particularly preferred. It is assumed to be 3.5 K gf.
又、 保持手段は、 例えば、 熱可塑性樹脂でブロ ー成形 に よ り ジ ャ バラ状に一体形成さ れたガイ ド カバーで構成 さ れる の が好 ま し レヽ 。 そ し て 、 特に 、 プ ロ 一成形で は ジ ャ バ ラ 状の ガイ ド カ バーの 、 外方へ張 り 出 し た山部 は、 内方へ く ぼんだ谷部よ り も 肉薄に容易に成形 し得る ので、 ガイ ド カバ一 と し て好適な特性が得られる 。  Further, it is preferable that the holding means is constituted by a guide cover integrally formed in a bellows shape by blow molding of a thermoplastic resin, for example. In particular, in the case of pro-molding, the outwardly protruding ridges of the guide cover in the form of a jar are thinner and easier than the valleys that are recessed inward. Since it can be formed into a shape, suitable characteristics as a guide cover can be obtained.
その他、 本発明の他の好ま し い具体的構成な らびに利 点につ いては以下に添付図面な らびにその図面を参照し てなさ れる以下の説明 よ .り理解で き る。  In addition, other preferred specific configurations and advantages of the present invention can be understood from the accompanying drawings and the following description made with reference to the drawings.
'図面の簡単な説明 'Brief description of the drawings
' 第 1 図乃至第 4 図は本発明の一実施例を示し、 第 1 図 は包材で覆われた状態の薬剤収納容器の斜視図、 第 2 図 は第 1 図の包材を除いた状態の薬剤収納容器の拡大し た 斜視図、 第 3 図は第 2' 図.に示す薬剤収納容器の、 特にガ ィ ド カ パー及び違通手段の部分の拡大縦断面図、 第 4 図 ( a) , ( b ) , ( c ) . ( d ) は薬剤収納容器の使用状態をそれぞれ 示す説明図、 第 5 図は本発明の他の実施例を示す薬剤収 納容器の斜視図であ る。  FIGS. 1 to 4 show an embodiment of the present invention. FIG. 1 is a perspective view of a medicine container covered with a packaging material, and FIG. FIG. 3 is an enlarged perspective view of the medicine container in the state, and FIG. 3 is an enlarged vertical sectional view of the medicine container shown in FIG. a), (b), (c) and (d) are explanatory views showing the usage state of the medicine container, respectively, and FIG. 5 is a perspective view of the medicine container showing another embodiment of the present invention. .
発明 を実施す る ための最良の形態  BEST MODE FOR CARRYING OUT THE INVENTION
以下、 本発明 の実施例 を添付図面に基づい て詳述す る。  Hereinafter, embodiments of the present invention will be described in detail with reference to the accompanying drawings.
第 1 図は包材で覆われた本発明の分離収納容器をなす 薬剤収納容器の斜視図、 第 2 図は薬剤収納容器の斜視図 であ る 。 両図にお いて :、 1 は薬剤 鈉容器を示 し.、 該薬 剤収納容器 1 は、 柔軟性のあ る合成樹脂シー ト に よ り 、 相互に独立 し た貯溜室 2 と収納室 3 と が一体に成形さ れ てな る 。 こ の薬剤収納容器 1 は、 長方形の包材 4 にて全 体が覆われてお り 、 こ の包材 4 に よ っ て貯溜室 2 内 に封 入さ れて い る後述の溶媒であ る溶解液 S の安定性が保証 さ れて い る。 該貯溜室 2 内に は溶解液 S 、 例え ば生理的FIG. 1 is a perspective view of a drug storage container forming a separation storage container of the present invention covered with a packaging material, and FIG. 2 is a perspective view of the drug storage container. It is. In both figures : 1 and 1 indicate a drug container, and the drug container 1 is made of a flexible synthetic resin sheet, and the storage chamber 2 and the storage chamber 3 are independent of each other. And are integrally formed. The medicine container 1 is entirely covered with a rectangular packaging material 4, and is a solvent described below, which is sealed in the storage chamber 2 by the packaging material 4. The stability of the dissolution solution S is guaranteed. Dissolution liquid S, for example, physiological
::. 食塩水若し く は 5 %ブ ド ウ糖液が 5 0 ない し 1 00 m £ が 入さ れてい る 。 第 2 図中、 貯溜室 2 の下部に は排出口 5 が設け られ、 更に排出口 5 にはアル ミ キ ヤ ッ ブ 6 が被 せられ、 溶解液 S が外部に出ない よ う にな っ て い る 。 :: There are 50 or 100 ml of saline or 5% glucose solution. In FIG. 2, a discharge port 5 is provided at the lower part of the storage chamber 2, and the discharge port 5 is further covered with an aluminum tube 6, so that the solution S does not go outside. ing .
収納容器 1 の一端部には、 後述する輸液ス タ ン ド 1 3 のハ ン ガー 1 4 に懸架す る ための孔 1 a が形成さ れる と 共に中間部には、 両室 2 , 3 を区画する境界部 1 b が形 At one end of the storage container 1, a hole 1a for hanging a hanger 14 of an infusion stand 13 to be described later is formed, and both chambers 2 and 3 are provided at an intermediate portion. Boundary part 1 b is shaped
. 成さ れている 。 貯溜室 2 の上部 と 前記収納室 3 の下部 と の間には、 貯溜室 2 内に位置 して分離可能な閉塞部 7 を 有する'' 'と 共に収納室 3 内に位置 して先端に刺通エ レメ ン 卜 をな'す瓶針又は刺通針 8 を有する連通手段をなす連通 部 9 が設け られてい る 。 こ の連通部は貯溜室 2 内の端部 が閉成さ れた筒状をな し 、 閉塞部 7 が外力の作用 で折れ 易い よ う に内周面に切欠が形成されている。 この瓶針 8 は返 り 刃 8 a が設け られ、 後述す る刺通部 1 1 に対 し て —度刺通 し たあ と抜けに く く なつ てい ^ 。 又、 筒状の連 通部 9 の 中 間部分 は 境界部 1 b に 保持 さ れ て い る 。 収納室 3 内に はガラ ス若 し く は'樹脂製の溶質収容部材 ¾ なすバイ ア ル又は溶質容器 1 0 が収納さ れ、 こ のバイ ァ ル 1 0 内の室 1 O b には粉末の溶質であ る抗生物質 Aが 入っ て レ、 る 。 こ のノヽ'ィ アル 1 0 の 口 1 0 a に は前述の瓶 針 8 を剌通可能な刺通部をなす ゴム栓 1 1 が嵌め られ、 口金 1 l a に よ り 固定さ れて いる (第 3 図) 。 又、 バイ アル 1 0 の口 1 0 a と 第 2 図中、 境界部 l b で形成され た収納室 3 の底部 3 a と の間にはジ ャバラ状のガイ ド カ バー 1 2 が設け られている。 こ のガイ ド カ ノヽ'一 1 2 が保 持手段を構成す る。 こ のガイ ド カ バ一 1 2 は、 例えば、 操作者の手で外部か ら所定以上の力が瓶針 8 の軸方向、 すなわ ち、 連通部 9 の瓶針 8 がバイ アル 1 0 の口 1 0 a に嵌め られたゴム栓 1 1 を刺通する方向にかか る と塑性 変形する材料、 例えば.、 アル ミ ニ ウ ム等の金属材料ゃポ リ プロ ピ レ ン等の熱可塑性樹脂によ り 構成されてい る 。 こ の ため 、. 所定以上の力が軸方向にかか ら ない限 り 瓶針 8 ば第 3 図で示す よ う に離間 し た位置に保持され、 ゴム 栓 1 1 を刺通する こ と がな く 、 誤っ て、 バイ アル 1 0 内 に溶解液 S が入る こ と がない 。 又、 こ のガイ ド カ バー 1 2 に よ り 瓶針 8 がガイ ド さ れ、 瓶針 8 が誤っ て ゴム栓 1 1 以外に刺通するのを防止している。 又、 一 、 ガイ ド カ バー 1 2 が変形して収縮する と 、 塑性変形であるか ら 、 その変形状態を ·維持するので、 瓶針 8 の刺通状態を 確実に保持する。 第 3 図 に 示 す よ う に 、 ガ イ ド カ バ 一 1 2 の 一 端部 1 2 a はノ ィ ア ルの口 1 0 a及びゴ ム栓 1 1 を囲む と と も にノ、'ィ アル 1 0 に固着さ れて いる。 ガイ ド カ ノ、一 1 2 の他端部 1 2 b は瓶針 8 を囲んだ状態でその軸方向に延 出 し て底部 3 a に固着さ れてい る。 Has been established. Between the upper part of the storage chamber 2 and the lower part of the storage chamber 3, there is a separable closing part 7 which is located in the storage chamber 2 and is located in the storage chamber 3 together with '' ′. A communication section 9 is provided as communication means having a bottle needle or a piercing needle 8 forming a communication element. The communicating portion has a cylindrical shape in which an end in the storage chamber 2 is closed, and a notch is formed in an inner peripheral surface so that the closing portion 7 is easily broken by an external force. The bottle needle 8 is provided with a return blade 8a, which makes it difficult for the piercing portion 11 to be described later to be pulled out. The middle part of the cylindrical communication part 9 is held at the boundary part 1b. Glass or resin solute storage member ¾ formed vial or solute container 10 is stored in storage room 3, and powder 1 is contained in chamber 1 Ob in this vial 10. The antibiotic A, which is a solute, enters. A rubber stopper 11 is inserted into the mouth 10a of this nodal 10 to form a piercing portion through which the above-mentioned bottle needle 8 can be pierced, and is fixed by a mouthpiece 1 la ( (Figure 3). A guide cover 12 in the form of a bellows is provided between the mouth 10a of the vial 10 and the bottom 3a of the storage chamber 3 formed by the boundary lb in FIG. I have. The guides 1 and 2 constitute the holding means. For example, the guide cover 12 applies an external force greater than a predetermined value by an operator's hand from the outside in the axial direction of the bottle needle 8, that is, the bottle needle 8 of the communication portion 9 is connected to the vial 10. A material that plastically deforms when it is put in the direction that penetrates the rubber plug 11 fitted into the mouth 10a, for example, a metal material such as aluminum or a thermoplastic material such as polypropylene. It is composed of resin. For this reason, as long as a predetermined force is not applied in the axial direction, the bottle needle 8 is held at a separated position as shown in FIG. 3, and the rubber stopper 11 can be pierced. In addition, the lysing solution S does not accidentally enter the vial 10. The guide cover 12 guides the bottle needle 8 to prevent the bottle needle 8 from being accidentally pierced except for the rubber stopper 11. Further, if the guide cover 12 is deformed and contracted, since it is plastically deformed, the deformed state is maintained, so that the piercing state of the bottle needle 8 is reliably maintained. As shown in FIG. 3, one end 12a of the guide cover 12 surrounds the mouth 10a of the dial and the rubber stopper 11 as well as the Fixed to dial 10. The other end 12b of the guide canopy 12 extends in the axial direction while surrounding the bottle needle 8 and is fixed to the bottom 3a.
ガ イ ド カ バ ー 1 2 を 熱塑性樹脂 で ブ ロ ー 成形 し た 場合、 第 3 図で示す よ う に、 ガイ ド カ ノく一 1 2 の、 半径 方向外方へ張 り 出 し た山部 1 2 c は半径方向内方へ く ぼ んだ谷部 1 2 d よ り も 肉薄にで き てい る ので、 ガイ ド カ バ一 1 2 の よ り 良好な伸縮性が得 られる。  When the guide cover 12 is blow-molded with thermoplastic resin, as shown in Fig. 3, the peaks of the guide cover 12 that protrude outward in the radial direction are formed. Since the portion 12c is thinner than the valley portion 12d which is recessed inward in the radial direction, better stretchability than the guide cover 12 can be obtained.
ガイ ド カ バー 1 2 を塑性変形させる外力の所定値は、 ノヽ'ィ アル 1 0 の ゴ ム栓 1 1 に対 し針 8 が剌通す る際の抵 抗、 つ ま り 刺通抵抗 と 同等か又はそれよ り 大に設定さ れ る のが望ま し レ、。  The prescribed value of the external force that causes the guide cover 12 to plastically deform is equivalent to the resistance when the needle 8 pierces the rubber stopper 11 of the nominal 10, that is, the piercing resistance. Or higher.
通常、 上記刺通抵抗は 3 K gf 程度である.か ら 、 上記ガ ィ ド カ バ一 Γ 2 所定値は、 こ.の場合、 最低値 と し て 3 Kgf に設定さ れ'る のがよい。 こ の所定値の上限は、 操 作者の加え得る外力に対応するが、 操作の容易性を考慮 し て所定値は 3 K gf 〜 5 Kgf の範囲内に設定さ れ、 特に 好ま し く は 3 . 5 Kgf であ る。  Usually, the piercing resistance is about 3 Kgf. Therefore, the predetermined value of the guide cover 2 is set to 3 Kgf as the minimum value in this case. Good. The upper limit of the predetermined value corresponds to the external force that can be applied by the operator, but the predetermined value is set in the range of 3 Kgf to 5 Kgf in consideration of the easiness of operation, and particularly preferably 3 Kgf. It is 5 Kgf.
なお 、 ガイ ド カ バー 1 2. を金属材料で形成す る場合 ブ レ ス成形の方法に よ る のが好ま し い。  When the guide cover 1 2. is formed of a metal material, it is preferable to use a method of press molding.
次に、 第 4 図 (a) , ( b ) , ( c ) , ( d) について上記構成にな る薬剤容器 1 の使用方法について述べる 。 ま ず、 こ の薬剤収納容器 1 を覆っ ている第 1 図に示す 包材 4 を取 り 除 く 。 そ し て、 収納室 3 内に収納さ れてい る ノ イ アル 1 0 の ロ 1 O a に嵌め られた ゴム栓 1 1 に 、 連通部 9 の瓶針 8 を 、 所定以上の外力でガイ ド カ バー 1 2·を軸方向 に塑性変形し て収縮させて、 刺通 し (第 4 図 ( a ) 参照) 、 更に連通部 9 の閉塞部 7 を破断ない し 分離 し て、 バイ アル 1 0 と貯溜室 2 と を連通部 9 を介 し て連通する (第 4 図 ( b ) 参照) 。 次に、 貯溜室 2 内に 封入さ れた溶解液 S を 、 貯溜室 2 を上に し て バイ アル 1 0 を下に し て連通部 9 を介 してバイ アル 1 0 内に注入 し て、 バイ アル 1 0 内の粉末の抗生物質 Aを溶解する。 粉末の抗生物質 Aを 解し た液をバイ ア ル 1 0 を上に し て貯溜室 2 を下に して貯溜室 2 に戻す。 上述の よ う な操 作を繰 り 返 し てバイ アル 1 0 内の粉末の抗生物質 A を 完全に溶解する (第 4 図 ( c ) 参照) 。 " Next, a method of using the medicine container 1 having the above configuration will be described with reference to FIGS. 4 (a), (b), (c) and (d). First, the packaging material 4 shown in FIG. 1 that covers the medicine container 1 is removed. Then, the bottle needle 8 of the communication part 9 is guided by a predetermined external force into the rubber stopper 11 fitted to the boiler 10 Oa of the neutral 10 housed in the storage room 3. The cover 12 ··· is plastically deformed in the axial direction and contracted by being plastically pierced (see FIG. 4 (a)). Further, the closed portion 7 of the communication portion 9 is not broken or separated and the vial 10 The reservoir and the storage chamber 2 are communicated via the communication part 9 (see FIG. 4 (b)). Next, the dissolving solution S sealed in the storage chamber 2 is injected into the vial 10 via the communication section 9 with the storage chamber 2 up and the vial 10 down. Dissolve the antibiotic A in the vial 10 in powder. The solution obtained by dissolving the powdered antibiotic A is returned to the storage chamber 2 with the vial 10 upward and the storage chamber 2 downward. The above procedure is repeated to completely dissolve the antibiotic A in the powder in the vial 10 (see Fig. 4 (c)). "
こ の薬剤収納容器 1 の孔 1 a を輸液スタ ン ド 1 3 のハ ンガー 1 4 に通 して、 薬剤収納容器 1 をハ ンガー 1 4 に 吊す (第 4図 ( d ) 参照) 。 すなわち、 粉末の抗生物質 A を溶解 し た液の入っ た貯溜室 2 を下に して薬剤収納容 器 1 をハ ンガー 1 4 に吊す こ と になる。 輸液セ ッ ト 1 5 は、 前記排出□ 5 を刺通する瓶針 1 _6 と 、 点滴筒 1 了 と ク レ ンメ 1 8 と患者 Mの血管等に刺通される静注針 1 9 と 、 これ ら を接続するチ ューブ 2 0 と か ら成る 。 The hole 1a of the medicine container 1 is passed through the hanger 14 of the infusion stand 13 and the medicine container 1 is hung on the hanger 14 (see FIG. 4 (d)). That is, the medicine container 1 is hung on the hanger 14 with the storage chamber 2 containing the liquid in which the powdered antibiotic A is dissolved down. The infusion set 15 includes a bottle needle 1 _ 6 piercing the discharge □ 5, a drip tube 1, a clamp 18, and an intravenous needle 19 pierced into a blood vessel or the like of the patient M. And a tube 20 connecting them.
第 4 図 ( d ) で示す よ う に、 輸液セ ッ ト 1 5 の静注針 1 9 を患者 Mの血管等に刺通 し 、 瓶針 1 6 を前記排出口 5 に被せ られたアル ミ キ ャ ッ プ 6 を取 り 外 し 、 排出ロ 5 に刺通 し 、 ク レ ン メ 1 8 を調節 し て薬剤収納容器 1 の貯 溜室 2 内の粉末の抗生物質 A を溶解 し た液を患者 M に点 滴静注す る 。 As shown in Fig. 4 (d), the IV needle of the infusion set 15 19 is pierced into the blood vessel or the like of the patient M, the bottle needle 16 is removed from the aluminum cap 6 placed on the discharge port 5, and pierced into the discharge port 5 to clean the bottle. Adjust the method 18 and inject the liquid in which the antibiotic A in the powder in the storage chamber 2 of the medicine container 1 is dissolved into the patient M by intravenous drip.
尚、 包材 4 (第 1 図) は、 前述 し た刺通操作で溶解液 S に抗生物質 A を溶解さ せた後で、 かつ、 輸液ス タ ン ド 1 3 にセ ッ 卜 する前に取 り 外 し て も よ い。  The packaging material 4 (Fig. 1) was prepared after the antibiotic A was dissolved in the dissolution solution S by the piercing operation described above, and before being set in the infusion stand 13. You can remove it.
第 5 図 は本発明の他の実施例を示す も ので、 第 2 図に 示す実施例 と 略同一の構成であ るか ら 、 同一部分.につい て は同一記号を付し てその説明 を省略する。 薬剤収納容 器 1 は、. 第 2 図に示す実施例では柔軟性の.ある合成樹脂 シー 卜 にて枏互に独立 し た貯溜室 2 と収納室 3 と が一体 に成形されてい る が、 本実施例は貯溜室 2 と収納室 3 0 と は别体になっ てい る。 収鈉'室 3 0 は外周面に ジ ヤ ノ ラ -状部分 3' 0 aが形成された円筒状を.な し ている。 こ の収. 納室 3 Ό の端面には吊 り 具 2 1 が取 り 付け られてい る 。 他の構成作用 については第 2 図に示す実施例 と 同 じ なの で省略す る 。 なお、 このジ ャ バラ状部分は 3 0 a はガイ ドカ バー 1 2 の軸方向への塑性変形を確実な も の と し 、 刺.通エ レ メ ン ト 8 の刺通状態を確霁な も の と する等の作 用効果を有す る 。  FIG. 5 shows another embodiment of the present invention, and since it has substantially the same configuration as the embodiment shown in FIG. 2, the same parts are denoted by the same symbols and their description is omitted. I do. In the embodiment shown in FIG. 2, the medicine storage container 1 has a flexible synthetic resin sheet in which the independent storage chamber 2 and the storage chamber 3 are integrally formed. In the present embodiment, the storage room 2 and the storage room 30 are integrated. The storage chamber 30 has a cylindrical shape with a janitor-shaped portion 3'0a formed on the outer peripheral surface. A hanging device 21 is attached to the end face of the storage room 3 こ. The other configuration and operation are the same as those in the embodiment shown in FIG. In addition, in this concavity-like portion, 30a ensures that the guide cover 12 is plastically deformed in the axial direction, and the piercing state of the penetration element 8 is confirmed. It has effects such as the following.
なお 、 本発明においては、 以上の実施例で開示 し た貯 溜室 2 と 溶質容器 1 0 の構成 を逆 と し て 、 貯溜室側 に 刺通部を設け、 溶質容器側に刺通エ レメ ン ト を設け る構 成を は じめ、 他の本発明の主旨を逸脱 し ない範囲の種々 の変形が可能であ り 、 実施例構成に限定さ れる ものでは な い 。 In the present invention, the configuration of the storage chamber 2 and the solute container 10 disclosed in the above embodiment is reversed, and In addition to the configuration in which a piercing portion is provided and a piercing element is provided on the solute container side, various modifications are possible without departing from the gist of the present invention. However, it is not limited to this.
産業上の利用可能性 Industrial applicability
以上の よ う に、 本発明にかかる分離収納容器は、 輸液 セ ッ 卜 に接続 し て患者に薬剤を点滴静注する ための点滴 用 バ ッ グ と して好適に用い られるが、 その他、 薬剤に限 ら ず粉末状若 し く は液状の溶質を無菌的 に溶媒に溶解 する必要のある分野において広ぐ利用 し得る。 . こ の よ う に、 本発明は薬剤等を取扱う '医用分野に限ら ず適用 し得る ものであ り 、 実施例において本発明の分離 収納容器の例と して薬剤収納容器を開示し たが、 こ れに よ っ て本発明の適用範囲が狭義の 「薬剤」 の関連の もの に と どま る ものではない。  As described above, the separation container according to the present invention is preferably used as an infusion bag for connecting a transfusion set to inject a drug intravenously into a patient. It can be widely used in fields where powdery or liquid solutes need to be aseptically dissolved in solvents. As described above, the present invention is applicable not only to the field of medicine for treating drugs and the like, but in the embodiment, the drug container is disclosed as an example of the separation container of the present invention. Therefore, the scope of the present invention is not limited to those related to “drugs” in a narrow sense.

Claims

請 求 ^) 範 囲 Claim ^) Range
1 . 排出 口 を有 し 且つ 内部に第 1 の物質が収容 さ れた 第 1 の室を有す る第 1 の収容部材と 、  1. a first storage member having a first chamber having an outlet and a first substance stored therein;
第 2 の物質を収容す る 第 2 の室 と 刺通部 と を有す る 第 2 の収溶部材 と 、 . '  A second fusible member having a second chamber for accommodating a second substance and a piercing portion;.
前記第 2 の収容部材の'刺通部を必要時所定の刺通抵抗 を も っ て刺通可能な刺通エ レメ ン 卜 と 前記第 1 の室内に 延出 し て常時は当該第 1 の室 と刺通エレメ ン 卜 と の連通 を閉鎖す る と共に必要時に分離可能であ り 、 分離 し た.と き に前記の連通を行なわせる 閉鎖部 と を有 し 、 必要時に 第 1 の室 と 第 2 の室 と の無菌的連通を行なわせ る連通手 段 と 、 . .  A piercing element capable of piercing the piercing portion of the second housing member with a predetermined piercing resistance when necessary; and a piercing element that extends into the first chamber and is always connected to the first chamber. The communication between the chamber and the piercing element is closed and separated when necessary, and a separation part is provided to allow the communication to be performed when necessary, and the first chamber is connected to the first chamber when necessary. A means of aseptic communication with the second chamber;
を備えてなる分.離収納容器において、 In a separate storage container,
前記第 2 の収容部材 と 第 1 の室 との間に配置さ れる と と も に前記刺通エ レメ ン ト を囲み、 且つ、 常時は前記第 2 の収容部材の刺 it部 と刺通エ レメ ン ト と を離間状態.に保 持する 'ど共に刺通エ レメ ン ト の軸'方向に沿 う 所定値以上 の外力が加わつ た時に当該軸方向に沿つ て塑性変形 して 前記刺通部に対する刺通エ レメ ン 卜 の.刺通を許容す る と 共に当該刺通状態を保持する保持手段が設け られ、 前記刺通エ レ メ ン ト に よ り 刺通部への刺通が な さ れた 後、 前記連通手段の閉鎖部が分'離さ れる こ と に よ り 当該 連通手段を介 し て第 1 の室 と第 2 の室と の間の無菌的連 通が行なわれる こ と を特徴と す る分雛収納容器。 It is disposed between the second housing member and the first chamber, surrounds the piercing element, and always pierces the piercing it portion of the second housing member. When the external force is applied along the direction of the axis of the piercing element together with a predetermined value or more, it is plastically deformed along the axial direction. A piercing element for the piercing portion is provided with holding means for permitting piercing and maintaining the piercing state, and piercing the piercing portion by the piercing element. After the communication is established, the closed portion of the communication means is separated, whereby aseptic communication between the first chamber and the second chamber is performed via the communication means. A separate container for chicks, characterized in that
2 . 前記 持手段を塑性変形さ せる外力の所定値は、 刺 通部に対す る刺通エ レメ ン 卜 の刺通抵抗 よ り 大で あ る こ と を特徴 と す る 請求の範囲第 1 項に記載の分離収納容 2. The predetermined value of the external force for plastically deforming the holding means is larger than the piercing resistance of the piercing element to the piercing portion. Separated storage volume described in section
3 - 前記保持手段 を塑性変形 'さ せ る 外力 の 所定値 は3-The predetermined value of the external force that causes the holding means to plastically deform is
3 Kgf 以上である こ と を特徴 と する請求の範囲第 2 項記 載の分離収納容器 The separated storage container according to claim 2, wherein the container is 3 kgf or more.
4 - 前記保持手段を塑性変形さ せる 外力の所定値は、 3 Kgf 〜 5 Kgf の範囲内にあ 0 、 好ま し く は、 3 . 5 Kgf であ る こ と を特徵 と する請求の範囲第 2 項記載の分離収 納容器。' 4-The predetermined value of the external force for plastically deforming the holding means is 0 in the range of 3 Kgf to 5 Kgf, preferably 3.5 Kgf. Separation container described in paragraph 2. '
5 . 前記保持手段は.ジ ャバラ状のガイ ド カ バ一よ り なる こ と を特徴と する請求の範囲第 1.項乃至第 4項のいずれ か 1 に記載の分離収納容器。 5. The separation container according to any one of claims 1 to 4, wherein the holding means comprises a guide cover having a bellows shape.
6 . 前記ガイ ド · カ バーは、 前記第 2 の収容部材の剌通 部を囲む と と も に当該第 2 の収容部材に固着さ れた一端 部 と 、 当該一端部よ り 剌通エ レ メ ン ト を囲っ て軸方向に 延出 し第 2 の収容部材を収納する収納室と前記第 1 の室 と を区画する境界部に固着さ れた他端部と を有する こ と を特徵と する請求の範囲.第 5項記載の分離収納容器。 6. The guide cover surrounds the stimulating portion of the second housing member and is fixed to the second housing member at one end, and the stimulating area is provided at the one end portion. It has a storage chamber that extends in the axial direction surrounding the ment and stores the second storage member, and has another end portion fixed to a boundary part that partitions the first chamber. The separated container according to claim 5.
7 - 前記連通手段は、 前記境界部に液密状態で固着さ れ た中央部 と 、 刺通エ レメ ン ト を取着 し た先端部 と 、 前記 閉鎖部を設けた基端部を有する連通部よ り なる こ と を特 徵 と す る請求の範囲第 6 項記載の分離収納容器 7-the communicating means comprises a central part fixed to the boundary part in a liquid-tight state, a distal end to which a piercing element is attached, and a proximal end provided with the closing part. The separation storage container according to claim 6, wherein the separation storage container is characterized by comprising:
8 . 前記ガイ ド カ バーは、 熱可塑性樹脂でブロ ー成形に よ り 一体に形成さ れる こ と を特徴 と する請求の範囲第 5 項記載の分離収納容器 8. The separation container according to claim 5, wherein the guide cover is formed integrally by blow molding with a thermoplastic resin.
9 . 前記ジ ャバラ状のガイ ド カ バーの、 外方へ張 り 出 し た山部は内方へ く ぼんだ谷部よ り も 肉薄に形成さ れる こ と を特徴 と す る請求の範囲第 5項記載の分離収納容器 9. The projecting ridge of the bellows-shaped guide cover is formed to be thinner than the valley recessed inward. Separation container described in paragraph 5
I, 0 . 前記ガイ ド カ バ一は、 金属材料でブ レス成形の方法 で一体 に形成されて な る こ と を.特徴 と す る 請求の範囲 第 5 項 載の分離収納容器。 I, 0. The separation and storage container according to claim 5, wherein the guide cover is integrally formed of a metal material by a press molding method.
I I . 前記第 1 の室は、 合成樹脂シー ト で形成さ れ、 当該 シー ト 内に前記第 2 の収容部材を収納する収納室が一体 に形成される こ と を特徵とする請求の範囲第 1 項記載の. 分離収納容器。 II. The first chamber, wherein the first chamber is formed of a synthetic resin sheet, and a storage chamber for storing the second storage member is integrally formed in the sheet. Item 1. A separate storage container.
1 2 . 前記第 1 の室は、 合成樹脂シー ト で形成さ れ、 前記 第 2 の取容部材を収納す る取納室が前記シー 卜 と 別体の 合成樹-脂シー ト で形成さ れる と と も に当該シー ト の外周 面にジ ャ バラ状部分が設け られる こ と を特徴と する請求 の範囲第 1 項記載の分離収納容器 12. The first chamber is formed of a synthetic resin sheet, and a storage chamber for storing the second receiving member is provided separately from the sheet. 2. The separation container according to claim 1, wherein the container is formed of a synthetic resin-fat sheet, and further has a rib-shaped portion provided on an outer peripheral surface of the sheet.
1 3 . 前記剌通エ レ メ ン ト は、 返 り 刃を形成 し た刺通針よ り なる こ と を特徴と する請求の範囲第 1 項記載の分離収 納.容器。 13. The container according to claim 1, wherein the stimulating element comprises a piercing needle having a return blade.
14. ·前記第 1 の物質は溶媒であ り 、 当該溶媒が前記第 1 の室をなす貯溜室に収容され、 前記第 2 ©物質は当該溶 媒に よ り 溶解さ れ'る溶質であ り 、 当該溶質は第 2 の収容 部材をなす溶質収容部材の内部に形成さ れた前記第 2 の 室に収容される こ と を特徵 と する請求の範囲第 1 項記載 の分離収納容器。 14. The first substance is a solvent, the solvent is contained in a storage chamber forming the first chamber, and the second substance is a solute dissolved by the solvent. The separation container according to claim 1, wherein the solute is stored in the second chamber formed inside a solute storage member forming a second storage member.
1 5 . 前記溶媒'は溶解液であ り 、 前記溶質は粉末薬剤であ る こ と を特徴 とする請求の範囲第 1 4項記載の分離収納 容器。 15. The separation container according to claim 14, wherein the solvent is a solution, and the solute is a powdered drug.
PCT/JP1988/000980 1987-09-28 1988-09-27 Separate storage container WO1989002730A1 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
DE1988908369 DE395758T1 (en) 1987-09-28 1988-09-27 CONTAINER FOR SEPARATE STORAGE.
EP88908369A EP0395758B1 (en) 1987-09-28 1988-09-27 Separate storage container
DE3850781T DE3850781T2 (en) 1987-09-28 1988-09-27 SEPARATE STORAGE CONTAINERS.

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP24308087A JPS6485653A (en) 1987-09-28 1987-09-28 Drug receiving container
JP62/243080 1987-09-28

Publications (1)

Publication Number Publication Date
WO1989002730A1 true WO1989002730A1 (en) 1989-04-06

Family

ID=17098480

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP1988/000980 WO1989002730A1 (en) 1987-09-28 1988-09-27 Separate storage container

Country Status (4)

Country Link
EP (1) EP0395758B1 (en)
JP (1) JPS6485653A (en)
DE (1) DE3850781T2 (en)
WO (1) WO1989002730A1 (en)

Cited By (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1990003775A1 (en) * 1988-10-11 1990-04-19 Fresenius Ag Container for the separate sterile storage of at least two substances and for mixing them
US5409141A (en) * 1992-03-13 1995-04-25 Nissho Corporation Two component mixing and delivery system
CN103702651A (en) * 2011-08-11 2014-04-02 费森尤斯医疗德国有限公司 Container for dialysis
US8967374B2 (en) 2006-05-18 2015-03-03 Dr. Py Institute Llc Delivery device with separate chambers connectable in fluid communication when ready for use, and related method
US9265858B2 (en) 2012-06-12 2016-02-23 Ferrosan Medical Devices A/S Dry haemostatic composition
US9527627B2 (en) 2011-05-18 2016-12-27 Fresenius Medical Care Deutschland Gmbh Connector for dialysis container, container equipped with such connector, manufacturing and filling method for such connectors and containers
US9533069B2 (en) 2008-02-29 2017-01-03 Ferrosan Medical Devices A/S Device for promotion of hemostasis and/or wound healing
US9724078B2 (en) 2013-06-21 2017-08-08 Ferrosan Medical Devices A/S Vacuum expanded dry composition and syringe for retaining same
US10111980B2 (en) 2013-12-11 2018-10-30 Ferrosan Medical Devices A/S Dry composition comprising an extrusion enhancer
US10653837B2 (en) 2014-12-24 2020-05-19 Ferrosan Medical Devices A/S Syringe for retaining and mixing first and second substances
US10918796B2 (en) 2015-07-03 2021-02-16 Ferrosan Medical Devices A/S Syringe for mixing two components and for retaining a vacuum in a storage condition
US11046818B2 (en) 2014-10-13 2021-06-29 Ferrosan Medical Devices A/S Dry composition for use in haemostasis and wound healing
US11109849B2 (en) 2012-03-06 2021-09-07 Ferrosan Medical Devices A/S Pressurized container containing haemostatic paste
US11801324B2 (en) 2018-05-09 2023-10-31 Ferrosan Medical Devices A/S Method for preparing a haemostatic composition

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5411499A (en) * 1988-01-25 1995-05-02 Baxter International Inc. Needleless vial access device
JPH077965Y2 (en) * 1990-11-14 1995-03-01 昭和電工株式会社 Infusion bag
US5776125A (en) 1991-07-30 1998-07-07 Baxter International Inc. Needleless vial access device
IT1251658B (en) * 1991-10-07 1995-05-19 Inge Spa SINGLE USE DEVICE PREFERABLY FOR HYGIENE-SANITARY USE.
US5352191A (en) * 1991-10-25 1994-10-04 Fujisawa Pharmaceutical Co., Ltd. Transfusion device
JPH05212090A (en) * 1992-02-04 1993-08-24 Material Eng Tech Lab Inc Transfusion container
JP3256583B2 (en) * 1992-12-10 2002-02-12 株式会社リコー Electrophotographic toner and method for producing the same
DE4314090C2 (en) * 1993-04-29 1997-09-04 Wolfgang Dr Vilmar Medical cutlery for the manufacture of a drug solution
US5547797A (en) * 1993-08-05 1996-08-20 Minolta Co., Ltd. Developer for developing electrostatic latent images
ES1037919Y (en) * 1997-07-16 1998-11-01 Inibsa Lab TWO LIQUID CONTAINER CARTRIDGE.
US5976115A (en) * 1997-10-09 1999-11-02 B. Braun Medical, Inc. Blunt cannula spike adapter assembly
US6159192A (en) 1997-12-04 2000-12-12 Fowles; Thomas A. Sliding reconstitution device with seal
US20050137566A1 (en) 2003-12-23 2005-06-23 Fowles Thomas A. Sliding reconstitution device for a diluent container
AR021220A1 (en) 1998-09-15 2002-07-03 Baxter Int CONNECTION DEVICE FOR ESTABLISHING A FLUID COMMUNICATION BETWEEN A FIRST CONTAINER AND A SECOND CONTAINER.
DE10005813A1 (en) * 2000-02-10 2001-08-23 Wolfgang Vilmar Mixing unit comprises container which is housed in hollow cylinder in further, axially displaceable hollow cylinder provided at its lower end with rubber membrane
WO2003055531A2 (en) * 2001-12-21 2003-07-10 Ferrosan A/S A hemostatic kit, a method of preparing a hemostatic agent and a method of promoting hemostasis
US7923431B2 (en) 2001-12-21 2011-04-12 Ferrosan Medical Devices A/S Haemostatic kit, a method of preparing a haemostatic agent and a method of promoting haemostatis
JP2006509502A (en) 2002-12-11 2006-03-23 フェローサン アクティーゼルスカブ Gelatin-based material as a swab
US7048724B2 (en) * 2002-12-17 2006-05-23 Denver Biomedicals, Inc. Device for withdrawing body fluids
EP1670409A1 (en) 2003-09-30 2006-06-21 Coloplast A/S A wound care device
US7641851B2 (en) 2003-12-23 2010-01-05 Baxter International Inc. Method and apparatus for validation of sterilization process
JP2007519450A (en) 2004-01-30 2007-07-19 フェロサン アー/エス Hemostasis sprays and compositions
DE102004021990B3 (en) * 2004-05-04 2005-11-10 Fresenius Kabi Deutschland Gmbh Medical container for administering a liquid consisting of a carrier solution and a medicament comprises a chamber provided with means for delivery of the medicament into the chamber holding the carrier solution
US7520919B2 (en) 2004-06-22 2009-04-21 Gambro Lundia Ab Transducer-protector device for medical apparatus
AU2005262070B2 (en) 2004-07-09 2011-01-27 Ferrosan Medical Devices A/S Haemostatic composition comprising hyaluronic acid
US20150005734A1 (en) * 2011-12-29 2015-01-01 Otsuka Pharmaceutical Factory, Inc. Exposure prevention cover, exposure prevention cover module provided with same, drug solution supply system, and drug solution supply method
EP2962676B1 (en) 2014-07-02 2017-03-22 Paolo Gobbi Frattini S.r.l. Flexible package with a sealed sterile chamber for the reconstitution and administration of fluid medicinal or nutritional substances instillable into the body of a patient
US9456956B1 (en) * 2015-09-29 2016-10-04 Siemens Medical Solutions Usa, Inc. Aseptic assembling of pharmaceutical containers
EP3508840A4 (en) * 2016-08-30 2020-04-15 Nipro Corporation Standard reagent kit for dialysis fluid analysis, and aqueous solution for standard reagent, dialysis fluid, and artificial kidney fluid replenishment
JP6642339B2 (en) * 2016-08-30 2020-02-05 ニプロ株式会社 Standard reagent kit for dialysate analysis
JP7003493B2 (en) * 2017-08-28 2022-02-04 ニプロ株式会社 Standard reagent kit for dialysate analysis
EP3427781A3 (en) * 2017-07-11 2019-05-01 Pharma Resources GmbH Drug and device system for pressurized aerosol therapies into a mammalian hollow space
US20210015707A1 (en) * 2018-04-13 2021-01-21 Fresenius Kabi Ab Container for a mixing system, mixing system for parenteral nutrition, and method for mixing
US11446209B2 (en) * 2018-04-13 2022-09-20 Fresenius Kabi Ab Arrangement and method for providing a formulation for parenteral nutrition

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS561559Y2 (en) * 1976-08-12 1981-01-14
JPS57500412A (en) * 1979-11-05 1982-03-11
JPH0523551B2 (en) * 1985-05-14 1993-04-05 Mitsubishi Electric Corp
JPH0614708Y2 (en) * 1989-10-17 1994-04-20 ホシザキ電機株式会社 Beverage warmer / cooler

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4589879A (en) * 1983-11-04 1986-05-20 Baxter Travenol Laboratories, Inc. Cannula assembly having closed, pressure-removable piercing tip

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS561559Y2 (en) * 1976-08-12 1981-01-14
JPS57500412A (en) * 1979-11-05 1982-03-11
JPH0523551B2 (en) * 1985-05-14 1993-04-05 Mitsubishi Electric Corp
JPH0614708Y2 (en) * 1989-10-17 1994-04-20 ホシザキ電機株式会社 Beverage warmer / cooler

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of EP0395758A4 *

Cited By (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1990003775A1 (en) * 1988-10-11 1990-04-19 Fresenius Ag Container for the separate sterile storage of at least two substances and for mixing them
US5409141A (en) * 1992-03-13 1995-04-25 Nissho Corporation Two component mixing and delivery system
US8967374B2 (en) 2006-05-18 2015-03-03 Dr. Py Institute Llc Delivery device with separate chambers connectable in fluid communication when ready for use, and related method
US9902508B2 (en) 2006-05-18 2018-02-27 Dr. Py Institute Llc Delivery device with separate chambers connectable in fluid communication when ready for use, and related method
US9533069B2 (en) 2008-02-29 2017-01-03 Ferrosan Medical Devices A/S Device for promotion of hemostasis and/or wound healing
US9527627B2 (en) 2011-05-18 2016-12-27 Fresenius Medical Care Deutschland Gmbh Connector for dialysis container, container equipped with such connector, manufacturing and filling method for such connectors and containers
CN103702651A (en) * 2011-08-11 2014-04-02 费森尤斯医疗德国有限公司 Container for dialysis
CN103702651B (en) * 2011-08-11 2016-08-17 费森尤斯医疗德国有限公司 container for dialysis
US10022299B2 (en) 2011-08-11 2018-07-17 Fresenius Medical Care Deutschland Gmbh Container for dialysis
US11109849B2 (en) 2012-03-06 2021-09-07 Ferrosan Medical Devices A/S Pressurized container containing haemostatic paste
US9999703B2 (en) 2012-06-12 2018-06-19 Ferrosan Medical Devices A/S Dry haemostatic composition
US10799611B2 (en) 2012-06-12 2020-10-13 Ferrosan Medical Devices A/S Dry haemostatic composition
US9265858B2 (en) 2012-06-12 2016-02-23 Ferrosan Medical Devices A/S Dry haemostatic composition
US9724078B2 (en) 2013-06-21 2017-08-08 Ferrosan Medical Devices A/S Vacuum expanded dry composition and syringe for retaining same
US10595837B2 (en) 2013-06-21 2020-03-24 Ferrosan Medical Devices A/S Vacuum expanded dry composition and syringe for retaining same
US10111980B2 (en) 2013-12-11 2018-10-30 Ferrosan Medical Devices A/S Dry composition comprising an extrusion enhancer
US11103616B2 (en) 2013-12-11 2021-08-31 Ferrosan Medical Devices A/S Dry composition comprising an extrusion enhancer
US11046818B2 (en) 2014-10-13 2021-06-29 Ferrosan Medical Devices A/S Dry composition for use in haemostasis and wound healing
US10653837B2 (en) 2014-12-24 2020-05-19 Ferrosan Medical Devices A/S Syringe for retaining and mixing first and second substances
US10918796B2 (en) 2015-07-03 2021-02-16 Ferrosan Medical Devices A/S Syringe for mixing two components and for retaining a vacuum in a storage condition
US11801324B2 (en) 2018-05-09 2023-10-31 Ferrosan Medical Devices A/S Method for preparing a haemostatic composition

Also Published As

Publication number Publication date
DE3850781D1 (en) 1994-08-25
EP0395758A4 (en) 1990-12-27
JPH0236261B2 (en) 1990-08-16
JPS6485653A (en) 1989-03-30
DE3850781T2 (en) 1995-02-23
EP0395758B1 (en) 1994-07-20
EP0395758A1 (en) 1990-11-07

Similar Documents

Publication Publication Date Title
WO1989002730A1 (en) Separate storage container
EP0282545B1 (en) Connector and a disposable assembly utilizing said connector
JP4838304B2 (en) Container with hollow needle
EP0079326A2 (en) Fluid transfer assembly
JPH06239352A (en) Solution injection set
WO1993025175A1 (en) Medical container
JPH0852196A (en) Transfusion container having connecting port for medicine
US5649907A (en) Device for dissolving and delivering a drug in a transfusion liquid
US8133204B1 (en) Medicament dispenser
US3938518A (en) Syringe attachment device
US6764463B1 (en) Method and needleless apparatus for the storage of a first substance followed by subsequent mixing with a second substance and transfer without ambient air incursion
KR20200005600A (en) Fill-Down Carriers for Drug Containers
JP5977734B2 (en) Puncture needle integrated adapter and method of using the puncture needle integrated adapter
DK201500380A1 (en) Intravenous Bag
JP2732610B2 (en) Medical liquid storage container
JP3003949B2 (en) Medical container
JP2004290218A (en) Multi-cell bag containing medicine and port member
KR101118835B1 (en) A solution receptacle integrated with medicine receptacle
WO1996025136A1 (en) Transfusion container
JP3025851B2 (en) Aseptic holding and mixing device for two drugs housed in individually sealed containers
US10980709B2 (en) Device for reconstituting and administering drugs
JPH04329957A (en) Germ-free holding/mixing apparatus for two kinds of medicines held in individually sealed container
JPH1128243A (en) Medical container
ES2954845T3 (en) Compact safety rapid refill pump for drug administration
JP4158446B2 (en) Filled bellows container

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): US

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): BE DE FR GB IT SE

WWE Wipo information: entry into national phase

Ref document number: 1988908369

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 1988908369

Country of ref document: EP

WWG Wipo information: grant in national office

Ref document number: 1988908369

Country of ref document: EP